Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

New insights into melanoma plasticity uncover a critical role of iron metabolism

  • medicalxpress.com language
  • 2025-09-19 00:30 event
  • 6 hours ago schedule
New insights into melanoma plasticity uncover a critical role of iron metabolism
VIB researchers and colleagues have discovered a mechanism through which melanoma cells adapt and switch between two major proliferative and invasive states, revealing promising new targets for cancer therapy.

26. Not all heart attack patients receive the same type of care, researchers find

  • 5 hours ago schedule
  • medicalxpress.com language

While acute myocardial infarction—commonly referred to as a heart attack—remains a leading cause of death in the United States, deaths have decreased significantly over the past two decades in part due to improved treatment methods, according to Charleen Hsuan, associate professor of health policy and administration at Penn State. However, not all patients may receive the recommended treatment.

27. How disrupted sleep and mood drugs impact women's hormonal and mental health

  • 5 hours ago schedule
  • medicalxpress.com language

A study from Taipei Medical University reveals how disruptions in the body's internal clock (caused by modern life and certain mood medications) can interfere with women's hormonal health and potentially worsen mood disorders. This research underscores the need for more rhythm-aware treatments that balance mental health and hormonal well-being.

28. AI-powered robot echocardiograms may alleviate wait times due to lack of trained sonographers

  • 5 hours ago schedule
  • medicalxpress.com language

Researchers at Cranfield University have been conducting a study in partnership with Milton Keynes University Hospital using an AI-controlled robotic system to deliver echocardiograms. The technology could eventually bring reduced waiting times and greater accessibility to complex scans of this kind.

29. Smartphone app boosts drug safety reporting in Uganda, trial finds

  • 5 hours ago schedule
  • medicalxpress.com language

Results from a new trial published in The Lancet Global Health show that a mobile application, Med Safety, improved the reporting of suspected adverse drug reactions (ADRs) by health care workers in Uganda.

30. Orange B food dye may soon be removed from US market, FDA says

  • 5 hours ago schedule
  • medicalxpress.com language

Federal health officials want to take Orange B—an artificial food dye that hasn't been used in more than four decades—off the books.

31. Tuberculosis vulnerability of people with HIV: Viral protein implicated

  • 5 hours ago schedule
  • medicalxpress.com language

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 times more likely to contract tuberculosis than HIV-uninfected people.

32. Vaccine death and side effects database relies on unverified reports—it's now being taken out of context

  • 6 hours ago schedule
  • medicalxpress.com language

Trump officials intend to link 25 child deaths to COVID-19 vaccines, according to reporting from The Washington Post. These findings will reportedly be discussed during the Sept. 18–19, 2025, meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, with implications for who may be eligible for COVID-19 vaccines in the future.

33. US medical panel insists it's 'pro-vaccine'

  • 6 hours ago schedule
  • medicalxpress.com language

A US panel stacked with figures sympathetic to the anti-vaccine movement opened a highly politicized meeting Thursday on the defensive, insisting that they are "pro-vaccine" even as public health experts fear the group is set to upend longstanding medical advice.

34. As obesity management medications explode in popularity, obesity experts issue caution on who should prescribe them

  • 6 hours ago schedule
  • medicalxpress.com language

The popularity of glucagon-like peptide-1 (GLP-1) agonists like Ozempic, Wegovy and Mounjaro has exploded in recent years. Initially approved to treat Type 2 diabetes, the drugs have become the tool of choice for millions of Americans, including influential celebrities, who wish to slim down. A recent survey even suggests that 1 in 8 Americans have received a prescription for them.

35. New insights into melanoma plasticity uncover a critical role of iron metabolism

  • 6 hours ago schedule
  • medicalxpress.com language

VIB researchers and colleagues have discovered a mechanism through which melanoma cells adapt and switch between two major proliferative and invasive states, revealing promising new targets for cancer therapy.

36. Progress slowing against non-communicable diseases, WHO warns

  • 6 hours ago schedule
  • medicalxpress.com language

Progress in the battle against non-communicable diseases like heart disease and cancer, which are the leading cause of death globally, has slowed, the World Health Organization warned Thursday.

37. Magnesium depletion linked to increased overactive bladder risk

  • 6 hours ago schedule
  • medicalxpress.com language

Magnesium depletion is associated with an increased risk for overactive bladder (OAB), according to a study published online Sept. 1 in Scientific Reports.

38. New kidney health guidance on impact and management of potassium and phosphorus additives released

  • 6 hours ago schedule
  • medicalxpress.com language

The American Society of Nephrology (ASN) today released its latest Kidney Health Guidance (KHG) addressing how potassium and phosphorus additives impact health risks (hyperkalemia and CKD-mineral and bone disorder) for people with kidney disease. The guidance, now available in the Journal of the American Society of Nephrology, was developed by the ASN KHG Workgroup on Food Additives to provide kidney care professionals with practical strategies to help patients understand and manage the consumption of potassium and phosphorus additives.

39. WHO backs new US focus on tackling chronic disease

  • 6 hours ago schedule
  • medicalxpress.com language

The World Health Organization said Thursday it backs US Health Secretary Robert F. Kennedy Jr.'s push for more focus on prevention to tackle chronic diseases.

40. Nonadherence to cervical cancer screening increased after COVID-19 pandemic

  • 6 hours ago schedule
  • medicalxpress.com language

Nonadherence to cervical cancer screening in the United States increased after the COVID-19 pandemic, according to a study published online Sept. 10 in PLOS Global Public Health.

41. At least one more governmental seat needed in Africa for stronger voice, better health, say experts

  • 6 hours ago schedule
  • medicalxpress.com language

Health funders would likely have a better return on investment and a stronger position in the global funding crisis if Africans had greater decision-making influence and voting power in global health institutions.

42. Why Florida's plan to end vaccine mandates will likely spread to other conservative states

  • 6 hours ago schedule
  • medicalxpress.com language

Florida Gov. Ron DeSantis announced a plan in early September 2025 that he intends to make Florida the first state to end vaccine mandates across all schools and in other state-run institutions such as nursing homes.

43. Does your child need more protein? The answer is probably not

  • 6 hours ago schedule
  • medicalxpress.com language

Protein is everywhere nowadays. From yogurt to breakfast cereal, bread to pasta or even chocolate bars, the obsession with making sure we get enough protein has seemingly taken over our diets.

44. WHO says 31 of 38 Ebola cases in Congo have resulted in deaths

  • 6 hours ago schedule
  • medicalxpress.com language

The World Health Organization said Thursday that 31 of 38 confirmed Ebola cases have resulted in deaths in southern Congo, where authorities are battling a new outbreak of the deadly virus.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.